A New Dawn for Alzheimer’s: Phase I Trial Targets Senescent Cells Safely
Wake Forest University researchers are exploring cellular senescence's role in Alzheimer's disease. By using a repurposed cancer drug and an antioxidant, initial tests show potential in targeting these problematic cells, but larger studies are needed for confirmation.
![](https://media.kbin.social/index.php/media/cache/resolve/entry_thumb/2f/4b/2f4b9e5834dc911f29af8cf6dfd8b4f46748bd7162e02ab360a1b5044718b09d.webp)